Ht-Logo-gigapixel-icon
Search
Close this search box.
Ht-Logo-gigapixel-icon
Search
Close this search box.
Saturday, November 2, 2024
Canada’s Politics and Government News Source Since 1989
Latest Paper
Saturday, November 2, 2024 | Latest Paper
Subscribe Now

TRENDING:

Gordon C. McCauley

Seizing the moment: building Canada’s academic leadership into a commercial powerhouse

  • Too much high-quality research is failing to make it out of laboratories to the benefit of patients and the Canadian economy.
Opinion | BY GORDON C. MCCAULEY | September 11, 2023
Canada is ranked ninth by the World Intellectual Property Organization, however this success has not translated into growth in domestic commercialization, writes Gordon McCauley, president and CEO of adMare BioInnovations. Photograph by rawpixel.com / Centers for Disease Control and Prevention, distributed under a CC0 1.0 license

Seizing the moment: building Canada’s academic leadership into a commercial powerhouse

Opinion | BY GORDON C. MCCAULEY | September 11, 2023
  • Too much high-quality research is failing to make it out of laboratories to the benefit of patients and the Canadian economy.

Seizing the moment: building Canada’s academic leadership into a commercial powerhouse

Opinion | BY GORDON C. MCCAULEY | September 11, 2023
  • Too much high-quality research is failing to make it out of laboratories to the benefit of patients and the Canadian economy.
Canada is ranked ninth by the World Intellectual Property Organization, however this success has not translated into growth in domestic commercialization, writes Gordon McCauley, president and CEO of adMare BioInnovations. Photograph by rawpixel.com / Centers for Disease Control and Prevention, distributed under a CC0 1.0 license

Seizing the moment: building Canada’s academic leadership into a commercial powerhouse

  • Too much high-quality research is failing to make it out of laboratories to the benefit of patients and the Canadian economy.
Opinion | BY GORDON C. MCCAULEY | September 11, 2023
Canada is ranked ninth by the World Intellectual Property Organization, however this success has not translated into growth in domestic commercialization, writes Gordon McCauley, president and CEO of adMare BioInnovations. Photograph by rawpixel.com / Centers for Disease Control and Prevention, distributed under a CC0 1.0 license

Seizing the moment: building Canada’s academic leadership into a commercial powerhouse

Opinion | BY GORDON C. MCCAULEY | September 11, 2023
  • Too much high-quality research is failing to make it out of laboratories to the benefit of patients and the Canadian economy.

Seizing the moment: building Canada’s academic leadership into a commercial powerhouse

Opinion | BY GORDON C. MCCAULEY | September 11, 2023
  • Too much high-quality research is failing to make it out of laboratories to the benefit of patients and the Canadian economy.
Canada is ranked ninth by the World Intellectual Property Organization, however this success has not translated into growth in domestic commercialization, writes Gordon McCauley, president and CEO of adMare BioInnovations. Photograph by rawpixel.com / Centers for Disease Control and Prevention, distributed under a CC0 1.0 license

It’s a generational moment for the life science industry

  • The race to develop and distribute COVID vaccines made it clear that Canada urgently needs a robust and well-coordinated life sciences sector.
Opinion | BY GORDON C. MCCAULEY | May 4, 2023
The federal government's major support of the life sciences in the pandemic was critical, but cannot stop there. Continued investment is needed so Canada can be a world leader in this key industry, writes Gordon C. McCauley. Photograph courtesy of Pixelbay

It’s a generational moment for the life science industry

Opinion | BY GORDON C. MCCAULEY | May 4, 2023
  • The race to develop and distribute COVID vaccines made it clear that Canada urgently needs a robust and well-coordinated life sciences sector.

It’s a generational moment for the life science industry

Opinion | BY GORDON C. MCCAULEY | May 4, 2023
  • The race to develop and distribute COVID vaccines made it clear that Canada urgently needs a robust and well-coordinated life sciences sector.
The federal government's major support of the life sciences in the pandemic was critical, but cannot stop there. Continued investment is needed so Canada can be a world leader in this key industry, writes Gordon C. McCauley. Photograph courtesy of Pixelbay
More Stories

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Advertise

get help

Subscribe
CloseMenu